Methods of treating inflammation

The present application is directed to depleting antigen binding sites which bind to CXCR3, and a method of using these antigen binding sites to treat autoimmune and inflammatory conditions, in particular, fatty liver disease, the accumulation of lipid deposits in the liver, steatoheptatits, graft r...

Full description

Saved in:
Bibliographic Details
Main Authors MACKAY, Charles Reay, ROBERT, Remy
Format Patent
LanguageEnglish
Published 15.04.2021
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present application is directed to depleting antigen binding sites which bind to CXCR3, and a method of using these antigen binding sites to treat autoimmune and inflammatory conditions, in particular, fatty liver disease, the accumulation of lipid deposits in the liver, steatoheptatits, graft rejection and conditions associated with effector and/or memory T cells.
Bibliography:Application Number: AU20190356521